Recipharm has received ISO 45001 certification for its Wasserberg facility in Germany as a result of the facility’s program to enhance sustainability and safety.
Recipharm, contract development and manufacturing organization (CDMO), has received ISO 45001 certification for its Wasserberg facility in Germany as a result of the facility’s program to enhance sustainability and safety.
ISO 45001 is the new working protection standard from the International Organization for Standardization (ISO), which was developed to improve employee safety, reduce workplace risk, and create better working conditions globally. The certification has been developed from an earlier one according to OSHAS 18001.
“Recipharm is committed to the ongoing development of its sustainability standards,” said Erik Haeffler, VP of Manufacturing Services and head of sustainability, in a Feb. 28, 2019 press release. “Achieving ISO 45001 at our first site demonstrates that we can perform to the highest standards when it comes to occupational health and safety. We now start the roll-out across our other facilities as we work towards ensuring we have management systems in place to manage not only occupational health and safety, but also other areas such as the environmental impact.”
Source: Recipharm
Telix Enters Agreement with ImaginAb to Purchase Next-Gen Therapeutic Candidates
Published: January 13th 2025 | Updated: January 13th 2025The transaction adds a pipeline of early-stage drug candidates against high-value targets to Telix’s portfolio, along with other novel targets currently in the discovery stage.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.